Related Experiment Video
Updated: Jul 30, 2025

Author Spotlight: Investigating the Underlying Mechanisms of Right Ventricular Failure in Pulmonary Hypertension
Published on: June 14, 2024
Hospital Procedural Volume and Clinical Outcomes Following Septal Reduction Therapy in Obstructive Hypertrophic
Ahmed M Altibi1, Fares Ghanem2, Yuanzi Zhao1
1Hypertrophic Cardiomyopathy Center, Division of Cardiology, Knight Cardiovascular Institute, Oregon Health and Science University Portland OR USA.
Septal myectomy (SM) for hypertrophic cardiomyopathy has a 4% in-hospital mortality, with lower mortality at high-volume centers. Alcohol septal ablation showed no volume-outcome relationship, but SM morbidity was substantial across all volumes.
Area of Science:
- Cardiovascular Surgery
- Interventional Cardiology
- Health Services Research
Background:
- Previous data indicated significant in-hospital mortality for septal myectomy (SM) in obstructive hypertrophic cardiomyopathy (oHCM).
- An inverse relationship between hospital procedure volume and patient outcomes was previously observed for SM.
- Contemporary outcomes and the volume-outcomes relationship for septal reduction therapies in oHCM require updated assessment.
Purpose of the Study:
- To evaluate current in-hospital outcomes for septal reduction therapies in obstructive hypertrophic cardiomyopathy.
- To analyze the relationship between hospital procedural volume and outcomes for both septal myectomy and alcohol septal ablation.
- To identify potential disparities in care based on hospital volume for these oHCM treatments.
Main Methods:
- Analysis of the National Readmission Databases for all septal reduction therapy admissions in the U.S. from 2010 to 2019.
- Stratification of hospitals into low-, medium-, and high-volume tertiles based on annual procedural volume of SM and alcohol septal ablation.
- Comparison of in-hospital mortality, adverse events, and 30-day readmission rates across different hospital volume groups for both procedures.
Main Results:
- Out of 19,007 patients, 12,065 (63%) underwent SM. Overall in-hospital mortality post-SM was 4.0%.
- Low-volume centers (<5 procedures/year) had significantly higher in-hospital mortality (5.7%), adverse events (21.3%), and 30-day readmissions (17.1%) compared to high-volume centers (2.4%, 12.6%, 9.7%, respectively).
- In-hospital mortality and other outcomes for alcohol septal ablation did not differ significantly across hospital volume tertiles.
Conclusions:
- A 4% in-hospital mortality rate for septal myectomy in obstructive hypertrophic cardiomyopathy persists, with a clear inverse volume-outcomes relationship.
- Mortality following alcohol septal ablation was consistent across all hospital volume levels.
- Substantial morbidity associated with septal myectomy was observed across all volume categories, highlighting the need for procedural centralization.
More Related Videos
07:24Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
Published on: April 8, 2013
09:40Induction of Right Ventricular Failure by Pulmonary Artery Constriction and Evaluation of Right Ventricular Function in Mice
Published on: May 13, 2019
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy V: Interprofessional Care
Mitral Stenosis I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy